Futibatinib

About

Therapy type: Targeted therapy

Therapy strategy: FGFR inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
EMA (1) FDA (1) FGFR2::v Intrahepatic Cholangiocarcinoma Futibatinib
EMA (1) FGFR2 rearrangements Intrahepatic Cholangiocarcinoma Futibatinib